Chimeric antigen receptor T cell therapy (CAR-T) is a new treatment for certain types of blood cancers that uses a person’s own immune cells (T cells) to destroy cancer cells.

CAR-T Cell Therapy - For Patients

What is CAR-T cell Therapy?

Chimeric antigen receptor T cell therapy (CAR-T) is a new treatment for certain types of blood cancers that uses a person’s own immune cells (T cells) to try to destroy cancer cells.
CAR-T Cell Therapy - For Clinicians

Information for clinicians

CAR-T therapy is publicly funded for specific indications and can also be accessed through clinical trials for some patient groups. Learn more about CAR-T therapy for your patients.
CAR-T Cell Therapy - Referrals

Referral information

We accept referrals for patients with B-cell Lymphoma and B-Precursor Acute-Lymphoblastic Leukaemia/Lymphoma. Learn more about the eligibility criteria and our referral process.
Have some feedback for us? Use our feedback process to let us know.
In the case of an emergency, call 000